Dynavax Technologies Corporation news

   Watch this stock
Showing stories 11 - 20 of about 85   

Articles published

DVAX 1.50 0.00 (0.00%)
price chart
Stocks in the Spotlight - BG Medicine, Inc. (NASDAQ:BGMD), Dynavax ...
Dynavax Technologies Corporation (NASDAQ:DVAX), a clinical-stage biopharmaceutical company, discovers and develops products to prevent and treat infectious and inflammatory diseases, and cancer.
Related articles »  
Investor's Watch List- Dynavax Technologies Corporation (NASDAQ:DVAX ...
Las Vegas, NV - April 3, 2014 - (TechSonian) �Dynavax Technologies Corporation (NASDAQ:DVAX) unveiled its financial results for the fourth quarter and year which ended on December 31, 2013.
Related articles »  
News Review - Dynavax Technologies Corporation (DVAX), Chelsea ...
Las Vegas, NV - April 15, 2014 - (TechSonian) - Dynavax Technologies Corporation (DVAX), a clinical-stage biopharmaceutical company, discovers and develops products to prevent and treat infectious and inflammatory diseases, and cancer.
Related articles »  
Hot Stock's Alert- Dynavax Technologies Corporation (DVAX), Canadian Solar ...
Dynavax Technologies Corporation (NASDAQ:DVAX) decreased -2.91% and closed at $1.67 in the last trading session with the overall traded volume of 1.91 million shares, versus the average volume of 3.45 million shares.
Related articles »  
Watch List: Community Health Systems (CYH), KeryxBiopharma (KERX ...
Find Out Here. Dynavax Technologies Corporation (DVAX) a clinical-stage biopharmaceutical company, discovers and develops products to prevent and treat infectious and inflammatory diseases, and cancer.
Dynavax Technologies Initiates Phase 3 Study Of HEPLISAV-B
Dynavax Technologies Corp. (DVAX: Quote) announced initiation of a new phase 3 clinical trial of HEPLISAV-B, its investigational adult hepatitis B vaccine.
Dynavax Initiates Phase 3 Study of HEPLISAV-B  Benzinga
Related articles »  
Investor's Alert - Dynavax Technologies Corporation (DVAX), Molycorp Inc (MCP ...
Dynavax Technologies Corporation (NASDAQ:DVAX) plunged -5.06% and closed at $1.69 on a traded volume of 2.92 million shares, in comparison to 4.13 million shares of average trading volume.
Stocks Buzz - Portugal Telecom, SGPS (ADR) (PT), Dynavax Technologies ...
Dynavax Technologies Corporation (DVAX) unveiled its financial results for the fourth quarter and year which ended on December 31, 2013.
Related articles »  
Healthcare Gainers: Inovio Pharmaceuticals (NYSEMKT:INO), Dynavax ...
On March 10, 2014, Dynavax Technologies Corporation (NASDAQ:DVAX) issued a press release announcing its financial results for the fourth quarter and year ended December 31, 2013.
Related articles »  
Stocks to Keep Your Eyes on: Dynavax Technologies Corporation (DVAX ...
Manhattan, NY- April 10, 2014 - (Techsonian) - Dynavax Technologies Corporation (NASDAQ:DVAX) reported financial results for the fourth quarter and year ended December 31, 2013.
Related articles »